Header Logo

Connection

AIKATERINI NELLA to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications AIKATERINI NELLA has written about Clinical Trials, Phase I as Topic.
AIKATERINI NELLA
Connection Strength
0.110
Clinical Trials, Phase I as Topic
  1. Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J Clin Endocrinol Metab. 2014 Sep; 99(9):3055-9.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.